In 1993, Lou Gerstner became CEO of a failing IBM, which faced massive losses and calls to be broken up. He rejected this, ...
Boston Scientific is a Buy with a $109 target and 14% upside from strong demand, Q3 beats, raised FY25 guidance, and growth ...